The nice people at the Stem Cell Evidence Alert sent their update today. I must admit that being on Christmas holiday I didn’t peruse it as much as I might have done… but thalidomide !?!That stuff is cropping up with more and more uses…
ARTICLE OF THE MONTH
Risk of relapse in patients receiving azithromycin after allogeneic HSCT.
Fresh versus Frozen Allogeneic Peripheral Blood Stem Cell Grafts: a Successful Timely Option.
Alotaibi, A. S., et al. (2020) American Journal of Hematology [record in progress]
Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis.
Atagundus, I. K. et al. (2020) Cancers [record in progress]
Donor Chimerism After Allogeneic Hematopoietic Stem Cells Transplant
For Myelofibrosis: The Role Of The Conditioning Regimen.
Chiusolo, P., et al. (2020) American Journal of Hematology [record in progress]
challenge of COVID-19 and hematopoietic cell transplantation; EBMT
recommendations for management of hematopoietic cell transplant
recipients, their donors, and patients undergoing CAR T-cell therapy.
Ljungman, P., et al. (2020) Bone Marrow Transplantation [record in progress]
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Cuadrado, M. M., et al. (2020) Haematologica [record in progress]
of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral
Blood Stem Cell Transplantation with Post-transplant Cyclophosphamide
in Patients with Acute Leukemia.
Nagler, A., et al. (2020) Clinical Cancer Research [record in progress]
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients.
Oran, B., et al. (2020) Blood Advances [record in progress]
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
Qayed, M., et al. (2020) Blood [record in progress]
Tacchetti, P., et al. (2020) The Lancet. Haematology [record in progress]